Akutes Nierenversagen – Update 2016

Zusammenfassung

Das akute Nierenversagen wird weiterhin durch die die Urinausscheidung und das Serum-Kreatinin als Parameter der Nierenfunktion definiert. Neue Biomarker können sinnvolle Ergänzungen im Hinblick auf die Pathogenese und Prognose sein. Eine Risikostratifizierung kann ebenfalls zur Identifikation gefährdeter Patienten beitragen und ist insbesondere aufgrund der eingeschränkten therapeutischen Optionen und der verheerenden Langzeitfolgen von besonderer Wichtigkeit.

Abstract

Acute kidney injury is still defined by the functional parameters diuresis and serum creatinine. New biomarkers can be sensible additions for the detection of pathogenesis and prognosis. Risk stratification is also very useful for identification of patients at risk for the developement of acute kidney injury. This is of increased imprtance as ausal therapeutic treatments are rare and long-term effects are devasting.

Schlüsselwörter

akutes Nierenversagen - Langzeitfolgen - Biomarker - Risikostratifzierung

Keywords

acute kidney injury - long-term outcome - biomarker - risk stratification

• Literatur

• 1 Selby NM, Crowley L, Fluck RJ et al. Use of electronic results reporting to diagnose and monitor AKI in hospitalized patients. Clin J Am Soc Nephrol 2012; 7: 533-540
• 2 Zeng X, McMahon GM, Brunelli SM et al. Incidence, outcomes, and comparisons across definitions of AKI in hospitalized individuals. Clin J Am Soc Nephrol 2014; 9: 12-20
• 3 Kerr M, Bedford M, Matthews B, O’onoghue D. The economic impact of acute kidney injury in England. Nephrol Dial Transplant 2014; 29: 1362-1368
• 4 Bienholz A, Kribben A. KDIGO-Leitlinien zum akuten Nierenversagen. Deutsche Übersetzung. Nephrologe 2013; 8: 247-251
• 5 Perazella MA. The Urine Sediment as a Biomarker of Kidney Disease. Am J Kidney Dis 2015; 66: 748-755
• 6 Wasung ME, Chawla LS, Madero M. Biomarkers of renal function, which and when?. Clin Chim Acta 2015; 438: 350-357
• 7 Koyner JL, Shaw AD, Chawla LS et al. Tissue Inhibitor Metalloproteinase-2 (TIMP-2)IGF-Binding Protein-7 (IGFBP7) Levels Are Associated with Adverse Long-Term Outcomes in Patients with AKI. J Am Soc Nephrol 2015; 26: 1747-1754
• 8 Koyner JL, Koyner JL, Davidson DL et al. Furosemide Stress Test and Biomarkers for the Prediction of AKI Severity. J Am Soc Nephrol 2015; 26: 2023-2031
• 9 Bienholz A, Wilde B, Kribben A. From the nephrologist’s point of view: diversity of causes and clinical features of acute kidney injury. Clin Kidney J 2015; 8: 405-414
• 10 Di Somma S, Lalle I, Magrini L et al. Additive diagnostic and prognostic value of bioelectrical impedance vector analysis (BIVA) to brain natriuretic peptide ‘grey-zone’ in patients with acute heart failure in the emergency department. Eur Heart J Acute Cardiovasc Care 2014; 3: 167-175
• 11 Honore PM, Jacobs R Hendrickx et al. Prevention and treatment of sepsis-induced acute kidney injury: an update. Ann Intensive Care 2015; 5: 51
• 12 Shiao CC, Wu PC, Huang TM et al. Long-term remote organ consequences following acute kidney injury. Crit Care 2015; 19: 438
• 13 Lai TS, Wang CY, Pan SC et al. Risk of developing severe sepsis after acute kidney injury: a population-based cohort study. Crit Care 2013; 17: R231
• 14 Wang WJ, Chao CT, Huang YC et al. The impact of acute kidney injury with temporary dialysis on the risk of fracture. J Bone Miner Res 2014; 29: 676-684
• 15 Chao CT, Wang CY, Lai CF et al. Dialysis-requiring acute kidney injury increases risk of long-term malignancy: a population-based study. J Cancer Res Clin Oncol 2014; 140: 613-621
• 16 Fortrie G, Stads S, Aarnoudse AJ et al. Long-term sequelae of severe acute kidney injury in the critically ill patient without comorbidity: a retrospective cohort study. PLoS One 2015; 10: e0121482